The short version
- Why people research itSoft-tissue and gut repair, reduced inflammation, angiogenesis and faster recovery from injury.
- What the evidence isPhase 3 in celiac disease — and it is an instructive failure.
- What to watchBlood in stool.
How Larazotide works
Larazotide is an eight-residue peptide, Gly-Gly-Val-Leu-Val-Gln-Pro-Gly, and its ancestry is worth knowing: it is modeled on a fragment of the Vibrio cholerae zonula occludens toxin, the bacterial protein that opens intestinal tight junctions during cholera. Add the residue masses and add water and you get about 726 Da — small, uncharged apart from its termini, mostly glycine and branched aliphatics.
What it is antagonizing. Zonulin, the endogenous protein that reversibly disassembles tight junctions, was identified as pre-haptoglobin-2 — the uncleaved precursor of a common haptoglobin variant — and shown to act through protease-activated receptor 2 with transactivation of the EGF receptor Tripathi 2009.
- Oral
On the goal map: Gut lining & mucosal repair (Heal an injury)
Research on Larazotide5 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Human clinical evidence
Phase 3 in celiac disease — and it is an instructive failure. Larazotide reached the largest celiac trial program ever run. The phase 3 was stopped early for futility against its primary endpoint.
Its earlier phase 2b had been positive on symptom scores, which is exactly the pattern that makes phase 3 necessary. Worth noting what the trial was asking: symptom relief in people already on a gluten-free diet, which is a narrow and demanding endpoint, not 'does it protect the gut barrier'.
Correlative data
Community use for intestinal permeability, largely on the strength of the mechanism rather than the phase 3 result. Reported experience is subtle.
How the mechanism reads
An octapeptide zonulin antagonist — zonulin regulates the tight junctions between intestinal epithelial cells, and larazotide is designed to keep them closed.
MechanisticThe mechanism is well characterized and the tight-junction effect is demonstrable. What the phase 3 questioned is whether closing tight junctions translates into how someone feels — a gap between mechanism and outcome that recurs constantly in gut-barrier research.
Mechanistic
Sources
- Leffler DA. Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.. Gastroenterology 2015 · PMID 25683116
- Leffler DA. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.. Am J Gastroenterol 2012 · PMID 22825365
- Tripathi A. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2.. Proc Natl Acad Sci U S A 2009 · PMID 19805376
- 9 Meters Biopharma Inc. Interim Analysis of Phase 3 Study of Larazotide for Celiac Disease Does Not Support Trial Continuation.. Company announcement, 21 June 2022
Larazotide safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Treating a suspected celiac disease with it instead of getting a diagnosis.
- Using it as permission to eat gluten.
- Allergy to its components.
- Pregnancy or breastfeeding, where trial exposure was excluded.
What’s expected
- Tight junctions between gut cells tighten as zonulin signaling is blocked.
- Tolerability comparable with placebo in a 342-patient celiac trial.
- Headache or mild nausea.
Watch for
- Blood in stool.
- Weight loss or ongoing diarrhea despite use.
- Rash with blisters, a gluten-related skin sign.
Labs that tell you it’s working
- Ferritin: persistent malabsorption shows as falling iron stores.
- Vitamin B12 & Folate: both depend on a healthy intestinal lining.
- Vitamin D (25-Hydroxy): a fat-soluble vitamin that drops with gut-barrier disease.
Zonulin antagonist peptide that tightens intestinal tight junctions; the best-studied gut barrier drug, with safety close to placebo. PMID 25683116 PMID 22825365 PMID 19805376
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Larazotide FAQ4 common questions
- Is Larazotide approved for human use?
- No. Larazotide is a research compound.
- What is Larazotide researched for?
- Soft-tissue and gut repair, reduced inflammation, angiogenesis and faster recovery from injury.
- Which labs show whether it's doing anything?
- Ferritin; Vitamin B12 & Folate; Vitamin D: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Larazotide: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



